TIOPRONIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tiopronin, and what generic alternatives are available?
Tiopronin is a drug marketed by Amneal, Endo Operations, Teva Pharms Inc, Torrent, and Teva Pharms Usa Inc. and is included in six NDAs.
The generic ingredient in TIOPRONIN is tiopronin. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tiopronin
A generic version of TIOPRONIN was approved as tiopronin by TEVA PHARMS USA INC on April 26th, 2021.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TIOPRONIN?
- What are the global sales for TIOPRONIN?
- What is Average Wholesale Price for TIOPRONIN?
Summary for TIOPRONIN
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 5 |
| Patent Applications: | 1,141 |
| DailyMed Link: | TIOPRONIN at DailyMed |
Recent Clinical Trials for TIOPRONIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| NYU Langone Health | Phase 2 |
| New York University School of Medicine | Phase 2 |
| Revive Therapeutics, Ltd. | Phase 2 |
Pharmacology for TIOPRONIN
| Drug Class | Reducing and Complexing Thiol |
| Mechanism of Action | Cystine Disulfide Reduction |
Anatomical Therapeutic Chemical (ATC) Classes for TIOPRONIN
US Patents and Regulatory Information for TIOPRONIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | TIOPRONIN | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216278-001 | Aug 15, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Torrent | TIOPRONIN | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216990-002 | Jan 30, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Inc | TIOPRONIN | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216456-001 | Jul 22, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
